RxDoctor Payments Data

Wayne Liles, MD

Infectious Disease · Seattle, WANPI 1629353271

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $11,850 of the $13,050 with a category attached, or 90.8%. Every reported general payment came from a single manufacturer, Roche Diagnostics International Ltd.

$13,050in general payments, 2019–2025

Across 3 payments — averaging $4350.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Roche Diagnostics International Ltd$13K
$1,009,518in research payments, 2019–2025

Across 7 payments — averaging $144,217 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Roche Diagnostics Corporation$1M

What the payments were for

  • Consulting fees$11,85091%
  • Speaking & faculty fees$1,2009%

General payments by program year

20
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Roche Diagnostics International Ltd3$13,050

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,050 in reported general payments places this provider in the 85th percentile of 186 infectious disease providers in Washington.

See all infectious disease providers in Washington

Medicare billing

Part B allowed, 2024
$6,486
Medicare patients
25
Services billed
44

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other infectious disease in Seattle

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →